| Toward more rational management for stage I testis cancer: watch out for "watch and wait"! |
| MB Garnick and JP Richie |
|
JCO Jul 1 1986: 1021–1023.
[PDF]
|
 |
| Randomized or historical control groups in cancer clinical trials: are historical controls valid? |
| EA Gehan |
|
JCO Jul 1 1986: 1024–1025.
[PDF]
|
|
| Guidelines, regulations, and clinical research |
| E Frei, 3d, JR Clark, and BG Fallon |
|
JCO Jul 1 1986: 1026–1030.
[PDF]
|
|
|
Prognostic factors in stage I non-seminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy |
| |
P Hoskin, S Dilly, D Easton, A Horwich, W Hendry, and MJ Peckham |
| |
JCO Jul 1 1986: 1031–1036.
[Abstract]
[PDF]
|
|
|
Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer |
| |
LH Einhorn, PJ Loehrer, SD Williams, S Meyers, T Gabrys, SR Nattan, R Woodburn, R Drasga, J Songer, and W Fisher |
| |
JCO Jul 1 1986: 1037–1043.
[Abstract]
[PDF]
|
|
|
Mortality and morbidity in long-term surviving patients treated with chemotherapy with or without irradiation for small-cell lung cancer |
| |
K Osterlind, HH Hansen, M Hansen, and P Dombernowsky |
| |
JCO Jul 1 1986: 1044–1052.
[Abstract]
[PDF]
|
|
|
A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas |
| |
CG Moertel, J Rubin, MJ O'Connell, AJ Schutt, and HS Wieand |
| |
JCO Jul 1 1986: 1053–1057.
[Abstract]
[PDF]
|
|
|
High-dose continuous infusion folinic acid and bolus 5-fluorouracil in patients with advanced colorectal cancer: a phase II study |
| |
M Bertrand, JH Doroshow, P Multhauf, DW Blayney, BI Carr, G Cecchi, D Goldberg, L Leong, K Margolin, and G Metter |
| |
JCO Jul 1 1986: 1058–1061.
[Abstract]
[PDF]
|
|
|
Improved survival in esophageal cancer in the period 1978 to 1983 |
| |
G Morstyn, RJ Thomas, M Mullerworth, DJ St. John, PS Bhathal, M Abbott, and R Van Cooten |
| |
JCO Jul 1 1986: 1062–1067.
[Abstract]
[PDF]
|
|
|
Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma |
| |
J Wils, G Blijham, A Naus, C Belder, F Boschma, H Bron, T Ceelen, A Eekhout, J von Erp, and P Geelen |
| |
JCO Jul 1 1986: 1068–1073.
[Abstract]
[PDF]
|
|
|
The value of hepatic ultrasound and biochemical liver tests in screening for liver metastases |
| |
MA Tempero, CA Williams, and JC Anderson |
| |
JCO Jul 1 1986: 1074–1078.
[Abstract]
[PDF]
|
|
|
High-dose cytosine arabinoside: treatment and cellular pharmacology of chronic myelogenous leukemia blast crisis |
| |
SJ Iacoboni, W Plunkett, HM Kantarjian, E Estey, MJ Keating, KB McCredie, and EJ Freireich |
| |
JCO Jul 1 1986: 1079–1088.
[Abstract]
[PDF]
|
|
|
Etoposide and cytosine arabinoside combination chemotherapy for refractory acute lymphocytic leukemia in childhood |
| |
N Esumi, S Todo, S Arakawa, and S Imashuku |
| |
JCO Jul 1 1986: 1089–1093.
[Abstract]
[PDF]
|
|
|
Combined modality treatment of cutaneous T cell lymphoma: results of a 6-year follow-up |
| |
CF Winkler, EA Sausville, DC Ihde, AB Fischmann, GP Schechter, PP Kumar, JR Nibhanupdi, JD Minna, RW Makuch, and JL Eddy |
| |
JCO Jul 1 1986: 1094–1100.
[Abstract]
[PDF]
|
|
|
Phase I study of multiple dose intramuscularly administered recombinant gamma interferon |
| |
R Kurzrock, JR Quesada, M Talpaz, EM Hersh, JM Reuben, SA Sherwin, and JU Gutterman |
| |
JCO Jul 1 1986: 1101–1109.
[Abstract]
[PDF]
|
|
|
Antiemetics in children receiving cancer chemotherapy: a double-blind prospective randomized study comparing metoclopramide with chlorpromazine |
| |
J Graham-Pole, J Weare, S Engel, R Gardner, P Mehta, and S Gross |
| |
JCO Jul 1 1986: 1110–1113.
[Abstract]
[PDF]
|
|
|
A comparison of randomized concurrent control groups with matched historical control groups: are historical controls valid? |
| |
LF Diehl and DJ Perry |
| |
JCO Jul 1 1986: 1114–1120.
[Abstract]
[PDF]
|
|
|
Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer |
| |
IF Tannock and G Browman |
| |
JCO Jul 1 1986: 1121–1126.
[Abstract]
[PDF]
|
|
|
Dealing with our losses |
| |
BM Mount |
| |
JCO Jul 1 1986: 1127–1134.
[Abstract]
[PDF]
|
|
| Intraperitoneal chemotherapy: a review |
| DE Brenner |
|
JCO Jul 1 1986: 1135–1147.
[PDF]
|
|
| Combination chemotherapy in advanced ovarian carcinoma |
| H Hochster |
|
JCO Jul 1 1986: 1148a.
[PDF]
|
|
| Circulating antigen levels in ovarian cancer |
| R Colomer, J Genolla, JM del Campo, and A Ruibal |
|
JCO Jul 1 1986: 1148b–1149.
[PDF]
|
|
| Philadelphia chromosome mosaicism in chronic granulocytic leukemia |
| ZA Arlin, S Jhanwar, and B Clarkson |
|
JCO Jul 1 1986: 1149–1150.
[PDF]
|
|
| Reversible increase in serum alpha-fetoprotein content associated with hepatic dysfunction during chemotherapy for seminoma |
| ES Newlands and KD Bagshawe |
|
JCO Jul 1 1986: 1150a.
[PDF]
|
|
| Chemotherapy in metastatic lung cancer |
| MD Goodyear |
|
JCO Jul 1 1986: 1150b–1152.
[PDF]
|
|
